Compare Johnson & Johnson (JNJ) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Nasdaq Inc — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Nasdaq Inc trades at $93.65 (market cap $51.63B). The key difference: Johnson & Johnson is far larger — about 12× Nasdaq Inc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Nasdaq Inc for 126 Days on average.
| JNJ | NDAQ | |
|---|---|---|
Market Cap | $618.09B | $51.63B |
Volume | 6,050,983 | 2,668,175 |
Sector | Health | Financials |
52-Week High | $278.43 | $100.98 |
52-Week Low | $186.00 | $76.85 |
Typical Hold Time | 129 Days | 126 Days |
Enterprise Value | $646.37B | $58.09B |
Dividend Yield | 2.09% | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
Nasdaq (NDAQ) trades at $92.37, up 0.48% with a bullish technical signal. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $1.07 versus $0.984, and revenue growth from $7.4B in 2024 to $8.3B in 2025. Recent news highlights Nasdaq's AI-powered Calypso platform adoption by HSBC and Moderna joining the Nasdaq-100 Index, signaling business momentum. Valuation metrics include P/E of 26.93 and P/S of 6.07, with analyst consensus price target at $110.43.
NDAQ presents a favorable outlook with consistent earnings beats and strategic AI integration driving growth. Risks include market volatility sensitivity and debt levels, but strong institutional support and bullish analyst ratings suggest upside potential. The stock's current price offers a 19.6% discount to consensus target, making it attractive for growth-oriented investors seeking exposure to financial technology and market infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
